Food and Drug Administration today approved an expanded indication for several transcatheter heart valves to include patients with severe aortic valve stenosis
(a narrowing of the heart's aortic valve that restricts blood flow to aorta, the body's main artery) who are at low risk for death or major complications associated with open-heart surgery to replace the damaged valves.
Food and Drug Administration announced today that certain transcatheter heart valves are now approved for use in patients with severe aortic valve stenosis
who have a low risk for death or major complications during open-heart surgery.
In particular, the study published in the European Heart Journal, shows that as body mass index (BMI) and fat mass increase, so does the risk of aortic valve stenosis
- a condition in which the valve controlling the flow of blood from the heart to the body's largest blood vessel, the aorta, narrows and fails to open fully.
For every one unit rise in BMI, the risk of disease ranged from 6% for pulmonary embolism to 13% for aortic valve stenosis
. Prof Susanna Larsson, of the Karolinska Institute in Sweden, did the research.
The days of open-heart surgery to treat aortic valve stenosis
may be limited, according to two ground-breaking studies presented at the 2019 American College of Cardiology (ACC) Annual Scientific Session.
Aortic valve stenosis
is the process of thickening and stiffening in the aortic valve, which can result in an abnormal narrowing of the aortic valve opening and reduction in blood flow.
And third, bicuspid aortic valve and aortic valve stenosis
: The aortic valve of this baby is abnormal and narrow."
The Mayo Clinic defines it as "a minimally invasive procedure to replace a narrowed aortic valve that fails to open properly (aortic valve stenosis
)." The procedure involves wedging a replacement valve into the aortic valve's place.
3, 2018 (HealthDay News) -- Long-term exposure to elevated blood pressure (BP) is associated with increased risk for aortic valve stenosis
(AS) and aortic regurgitation (AR), according to a study published online Sept.
Incidence and prognosis of congenital aortic valve stenosis
in Liverpool (1960-1990).
Transcatheter aortic valve replacement (TAVR) is a minimally invasive procedure used to replace the aortic valve in people with aortic valve stenosis
or a narrowing of that valve.